(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIPAD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIPAD

ST13

US500000086945392

Class

5, 42

Filing

86945392

Registration

5760160

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

02/25/2025

Trademark type

Word

Nice classes

5, 42

Filing date

03/18/2016

Registration date

05/28/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/31/2025

Last transaction

02/25/2025

Responsible office

United States Patent and Trademark Office

Status code

705

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

03

Owner location

Taipei City 11503, TW

Examiner

HESIK, APRIL

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TAIWAN LIPOSOME CO., LTD.

Representatives

Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Allergy medications; antibacterial pharmaceuticals; antibiotic preparations; antibiotics; antifungal preparations; anti-cancer preparations; anti-diabetic preparations; anti-inflammatories; aspirin; lipid-based preparations for medical or clinical use; cardiovascular treatment preparations; cells for medical or clinical use; chemotherapeutics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated skin care preparations; ophthalmic preparations; pain relief medication; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; radioactive pharmaceutical preparations for therapeutic use

Class 42

Biochemical research and development; biomedical research services; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; chemicalbiochemicalbiological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific researchconducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems

Publications

History of USPTO decisions and trademark events.

57 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/31/2025

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/31/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/31/2025

E815

TEAS SECTION 8 & 15 RECEIVED

09/16/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/28/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/23/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/23/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/23/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/23/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/28/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/12/2019

PUBO

PUBLISHED FOR OPPOSITION

03/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/20/2019

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/06/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/29/2019

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

01/29/2019

OTHE

CASE RETURNED TO EXAMINATION

01/28/2019

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

01/22/2019

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

01/22/2019

IUCN

NOTICE OF ALLOWANCE CANCELLED

01/14/2019

ERTI

TEAS RESPONSE TO PETITION INQUIRY LETTER

01/14/2019

PILM

PETITION INQUIRY LETTER ISSUED

01/14/2019

APET

ASSIGNED TO PETITION STAFF

01/14/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/06/2018

EX3G

SOU EXTENSION 3 GRANTED

11/02/2018

EXT3

SOU EXTENSION 3 FILED

11/02/2018

EEXT

SOU TEAS EXTENSION RECEIVED

11/02/2018

TPDR

TEAS PETITION TO DIRECTOR RECEIVED

11/02/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/18/2018

EX2G

SOU EXTENSION 2 GRANTED

05/16/2018

EXT2

SOU EXTENSION 2 FILED

05/16/2018

EEXT

SOU TEAS EXTENSION RECEIVED

05/16/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/18/2017

EX1G

SOU EXTENSION 1 GRANTED

11/16/2017

EXT1

SOU EXTENSION 1 FILED

11/16/2017

EEXT

SOU TEAS EXTENSION RECEIVED

11/16/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/16/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/21/2017

PUBO

PUBLISHED FOR OPPOSITION

03/21/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/01/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/13/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/27/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/25/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/25/2017

ALIE

ASSIGNED TO LIE

01/20/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/27/2016

GAUN

NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

09/12/2016

GAUD

NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED

09/12/2016

NAUD

REPORT UNRESPONSIVE AMENDMENT - COMPLETED

09/12/2016

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

09/08/2016

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

09/08/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/28/2016

GNRT

NON-FINAL ACTION E-MAILED

06/28/2016

CNRT

NON-FINAL ACTION WRITTEN

06/28/2016

DOCK

ASSIGNED TO EXAMINER

06/28/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/23/2016

NWAP

NEW APPLICATION ENTERED

03/22/2016

Continuous trademark protection

Get notified about every new filing that threatens LIPAD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.